If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,330.00
Bid: 1,328.00
Ask: 1,336.00
Change: 20.00 (1.53%)
Spread: 8.00 (0.602%)
Open: 1,318.00
High: 1,336.00
Low: 1,298.00
Prev. Close: 1,310.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GBP15.3m Placing for Fast Data Opportunities

12 Feb 2015 07:00

RNS Number : 6953E
First Derivatives PLC
12 February 2015
 



12 February 2015

First Derivatives plc

("FD" or the "Company")

 

Placing of 1,177,003 new ordinary shares to raise £15.3mto accelerate Fast Data Opportunities

Exercise of share options

Notice of Shareholders' General Meeting

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services , is pleased to announce that it has conditionally placed 1,177,003 new ordinary shares of 0.5p each (the "Placing Shares") at £13.00 per share, with a number of existing and new institutional investors to raise approximately £15.3m (the "Placing").

 

The Placing has been undertaken by Charles Stanley Securities and Goodbody to satisfy strong investor demand following the announcement on 31 October 2014 that the Company had increased its shareholding in Kx Systems Inc. ("Kx Systems") and the Company's interim results to 31 August 2014 released on 5 November 2014. The Company confirms that trading for the year to 28 February 2015 remains in line with market expectations.

 

Use of Proceeds

The estimated net proceeds of the Placing of £14.7m will be employed to give the Company the flexibility to pursue certain additional growth opportunities which the Board has identified. The funds raised through this placing will be used to strengthen our market share in capital markets and to facilitate entry into new verticals through partnerships, acquisitions and the acceleration of our product roadmap.

 

 

Brian Conlon, Chief Executive Officer of FD, commented: "I would like to thank existing investors for their continued support and welcome new investors to the Company. Our recent investment in Kx Systems and preliminary market research in other verticals, strengthens our view that we can generate significant additional returns for shareholders by expanding our Fast Data offering beyond capital markets."

 

 

Details of Placing

The placing price of £13.00 per Placing Share represents a premium of 0.8 per cent to the Company's closing mid-market price on 11 February 2015 of £12.90 per share.

 

The Placing is being conducted in two tranches. The first tranche of the Placing (the "First Placing") comprises 977,000 Placing Shares (the "First Placing Shares"), which have been placed utilising in full the Company's authority to issue shares for cash approved by Shareholders at the last Annual General Meeting.

 

To accommodate the strong level of demand from institutional investors, the Company is also placing a second tranche of Placing Shares (the "Second Placing"). The Second Placing will require approval by Shareholders and the Company is therefore seeking authority from Shareholders to issue a further 200,003 Placing Shares (the "Second Placing Shares") which have been placed conditional upon Shareholders passing a special resolution at a General Meeting to be held on 3 March 2015 (the "General Meeting"). Shareholders will be asked to grant authority to issue the Second Placing Shares (the "Resolution").

 

Application has been made for the First Placing Shares to be admitted to trading on AIM and the ESM (the "First Admission") and a further application has been made for the Second Placing Shares to be admitted to trading on AIM and the ESM (the "Second Admission"). The First Placing is conditional, inter alia, upon the First Admission becoming effective which is expected to be on 17 February 2015. The Second Placing is subject, inter alia, to Shareholders passing the Resolution and the Second Admission becoming effective which is expected to be on 4 March 2015.

 

The Company also announces the issue and allotment of 65,000 new ordinary shares of 0.5p each (the "Option Shares") pursuant to the exercise of share options by two employees. The Option Shares have also been placed with an institutional investor, also at £13.00 per Option Share.

 

Application has been made for the Option Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 17 February 2015.

 

The Placing Shares and the Option Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Upon First Admission (that is admission of the First Placing Shares and the Option Shares), the total issued share capital of the Company will increase to 22,643,584 Ordinary Shares. Upon the Second Admission (namely admission of the Second Placing Shares) the total issued share capital of the Company will increase to 22,843,587 Ordinary Shares. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a charge to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company will be 22,843,587.

 

Arden Partners acted as Placing Agent on the Placing.

 

General Meeting

The Resolution being proposed is to authorise the issue of the 200,003 Placing Shares proposed to be issued pursuant to the Second Placing.

 

A General Meeting of the Company is to be held at 10.00 a.m. on 3 March 2015 at 3 Canal Quay, Newry, Co. Down, BT35 6BP at which the Resolution will be proposed. Notice of the General Meeting, together with details of the Placing, are set out in a circular which has been sent to Shareholders. A copy of the Circular is also available on the Company's web site www.firstderivatives.com.

 

At the Annual General Meeting of the Company held on 26 June 2014, Shareholders passed resolutions in order (i) to grant the Directors authority to allot equity securities up to a maximum nominal value of £32,569representing 6,513,800 Ordinary Shares and (ii) to disapply statutory pre-emption rights to allow the allotment by the Directors of equity securities for cash up to an aggregate nominal value of £4,885representing 977,000 Ordinary Shares without the requirement for such equity securities to be first offered to existing Shareholders.

 

The placing of the First Placing Shares will utilise the authority set out in (ii) above. The Second Placing Shares will therefore require authority in excess of the Company's existing authority to issue shares for cash on a non-pre-emptive basis. Accordingly, the placing of the Second Placing Shares is conditional on the passing by the Shareholders of the Resolution.

 

The Resolution requests that Shareholders grant a further waiver to disapply statutory pre-emption rights to allow the allotment by the Directors of equity securities for cash up to an aggregate nominal value of £5,660 representing approximately 5% of the issued share capital of the company as at the date following the First Admission without the requirement for such equity securities to be first offered to existing Shareholders.

 

If given, the authority will expire on the conclusion of the Company's 2015 annual general meeting.

 

 

Directors' recommendation

The Directors believe that the Placing and the associated Resolutions are in the best interests of the Company and of Shareholders taken as a whole. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the Resolution, as they intend to do in respect of their own shareholdings, which in aggregate total 8,221,914 Ordinary Shares representing approximately 38.0 per cent. of the Existing Ordinary Shares.

 

 

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser& Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody

(ESM Adviser & Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0410

Walbrook PR

Financial PR

Paul Cornelius

Sam Allen

Nick Rome

+44 (0)20 7933 8780

 

firstderivatives@walbrookpr.com

 

 

About FD

 

FD is a global provider of software and consulting services. With over 18 years' experience working with leading financial and technology institutions, it continues to deliver technologically advanced, award winning products and services that anticipate and respond to the evolving needs of global markets. F D currently employs over 1,200 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It also holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It has operations in London, New York, Stockholm, Singapore, Hong Kong, Sydney, Toronto, Philadelphia, Dublin and its headquarters in Newry.

 

For further information please visit www.firstderivatives.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOURVAAUAUR
Date   Source Headline
15th Jun 20186:01 pmRNSHolding(s) in Company
8th Jun 20188:00 amRNSEnterprise Securities Market Notice
7th Jun 201810:43 amRNSHolding(s) in Company
5th Jun 20184:51 pmRNSNotice of AGM
1st Jun 20184:14 pmRNSIssue of Equity
22nd May 20187:00 amRNSPreliminary results for the year ended 28 Feb 2018
17th May 20187:02 amRNSKx provides rapid access to unstructured data
25th Apr 20187:00 amRNSTrading update and Notice of Results
3rd Apr 201810:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSEnterprise Securities Market Notice
19th Mar 201810:09 amRNSIssue of Equity
28th Feb 20189:01 amRNSTotal Voting Rights
20th Feb 20187:00 amRNSContract Win in Gaming
7th Feb 20187:00 amRNSEnterprise Securities Market Notice
1st Feb 20185:23 pmRNSIssue of Equity
31st Jan 20183:40 pmRNSTotal Voting Rights
15th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:00 amRNSEnterprise Securities Market Notice
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSIssue of Equity
19th Dec 20174:06 pmRNSDirector/PDMR Shareholding
18th Dec 20174:07 pmRNSIssue of Equity
14th Dec 20177:00 amRNSEnterprise Securities Market Notice
11th Dec 20177:00 amRNSTelco Acquisition
7th Dec 20177:00 amRNSEnterprise Securities Market Notice
1st Dec 20174:31 pmRNSIssue of Equity
30th Nov 20178:36 amRNSTotal Voting Rights
22nd Nov 201710:35 amRNSHolding(s) in Company
21st Nov 20174:54 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSEnterprise Securities Market Notice
10th Nov 201712:32 pmRNSIssue of Equity and Dividend Timetable Amendment
7th Nov 20177:00 amRNSHalf Yearly Report
6th Nov 20177:00 amRNSKx selected by Red Bull Racing
13th Oct 20177:00 amRNSNotice of Results
2nd Oct 20179:09 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSMajor Machine Learning Investment in Kx Technology
5th Sep 20177:00 amRNSEnterprise Securities Market Notice
30th Aug 20173:04 pmRNSIssue of Equity
23rd Aug 201712:20 pmRNSHolding(s) in Company
31st Jul 201711:58 amRNSTotal Voting Rights
28th Jul 20177:00 amRNSEnterprise Securities Market Notice
25th Jul 20177:00 amRNSHolding(s) in Company
24th Jul 20174:26 pmRNSIssue of Equity from exercise of Share Options
7th Jul 20177:00 amRNSEnterprise Securities Market Notice
3rd Jul 20174:23 pmRNSIssue of Equity from exercise of Share Options
30th Jun 201710:48 amRNSTotal Voting Rights
23rd Jun 20171:50 pmRNSAGM Statement
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.